ChromoGenics AB reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 15.7 million compared to SEK 24.44 million a year ago. Net loss was SEK 52.51 million compared to SEK 56.98 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.78 SEK | -3.14% | -13.52% | -3.14% |
Apr. 02 | ChromoGenics AB Receives First Order for North America | CI |
Mar. 08 | ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.14% | 4.1M | |
+18.22% | 7.17B | |
+5.12% | 2.36B | |
+6.58% | 1.02B | |
+22.43% | 817M | |
0.00% | 404M | |
+4.88% | 362M | |
+7.79% | 231M | |
+14.62% | 192M | |
+11.11% | 169M |
- Stock Market
- Equities
- CHRO Stock
- News ChromoGenics AB
- ChromoGenics AB Reports Earnings Results for the Full Year Ended December 31, 2023